SCHEMBL23224028

SCHEMBL23224028

COC(=O)C(=O)c1cc(C(=O)OC)c2n1CCCC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
KCNK3 O14649 7/20 0.43
MAPK1 P28482 1/20 0.42
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
PDE3B Q13370 4/20 0.39
PDE3A Q14432 4/20 0.39
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23223827 0.96 MAPK1 (0.47) ALDH1A1KCNK3MAPK1KMT2AMEN1
SCHEMBL21809669 0.90 ALDH1A1 (0.48) ALDH1A1KCNK3MAPK1KMT2AMEN1
SCHEMBL23223818 0.90 ALDH1A1 (0.48) ALDH1A1KCNK3MAPK1KMT2AMEN1
SCHEMBL21810200 0.88 PDE3B (0.47) ALDH1A1KCNK3MAPK1PDE3BPDE3A
SCHEMBL23223970 0.86 MAPK1 (0.46) ALDH1A1KCNK3MAPK1KMT2AMEN1
SCHEMBL21809589 0.86 MAPK1 (0.46) ALDH1A1KCNK3MAPK1KMT2AMEN1
SCHEMBL23223987 0.84 MAPK1 (0.44) ALDH1A1KCNK3MAPK1KMT2AMEN1
SCHEMBL21809985 0.84 ALDH1A1 (0.43) ALDH1A1KCNK3MAPK1KMT2AMEN1
SCHEMBL21810330 0.84 PDE3B (0.50) ALDH1A1KCNK3MAPK1KMT2AMEN1
SCHEMBL24571109 0.81 ALDH1A1 (0.39) ALDH1A1KCNK3MAPK1KMT2APDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204510-A1 2,3-DIHYDRO-1H-PYRROLIZINE-7-FORMAMIDE DERIVATIVE AND APPLICATION THEREOF CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2022-06-30 US disclosed
EP-3805223-A1 2,3-DIHYDRO-1H-PYRROLIZINE-7-FORMAMIDE DERIVATIVE AND APPLICATION THEREOF Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2021-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204510-A1 2,3-DIHYDRO-1H-PYRROLIZINE-7-FORMAMIDE DERIVATIVE AND APPLICATION THEREOF DPYD, EIF2AK2, INF2 ALDH1A1 2381/4885KCNK3 4596/4885MAPK1 3049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.